PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric field device shows promise against tough pancreatic cancer
Disease control Recruiting nowThis study tests a wearable device that creates electric fields (TTFields) combined with chemotherapy for people with metastatic pancreatic cancer that has spread. The goal is to see if adding the device to standard chemo is safe and can help control the disease. About 30 adults …
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the experimental drug atebimetinib to standard chemotherapy helps people with metastatic pancreatic cancer live longer. About 510 adults who have not had prior treatment will be randomly assigned to receive either the new combination or standard ch…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Stem cell combo trial aims to outsmart Drug-Resistant cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with metastatic pancreatic or breast cancer that has stopped responding to standard therapies. The treatment combines two chemotherapy drugs with high-dose vitamins and a stem cell transplant to help the body recover. The ma…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for pancreatic cancer: targeted drug combo enters phase 3 trial
Disease control Recruiting nowThis study tests a new drug called daraxonrasib, either alone or with standard chemotherapy, for people with metastatic pancreatic cancer that has spread. About 900 adults with a RAS gene mutation will be randomly assigned to one of three treatment groups. The goal is to see if t…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug cocktail takes on tough pancreatic cancer
Disease control Recruiting nowThis early-phase trial is testing a new drug called OMTX705, which targets a protein found on cancer-supporting cells, combined with standard chemotherapy and an immunotherapy for people with advanced pancreatic cancer that has spread. The study aims to find the safest dose and s…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo therapy aims to halt pancreatic cancer progression
Disease control Recruiting nowThis study tests whether combining niraparib and ipilimumab can slow tumor growth in people with metastatic pancreatic cancer that has not worsened after initial platinum chemotherapy. About 68 adults will be randomly assigned to receive either the drug combo or standard chemothe…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 06, 2026 16:03 UTC